Applied Biology

Name

Applied Biology

Website

https://appliedbiology.com

Company type

Private

Headcount range

1–10 employees

Short description

Applied Biology is a privately held, Irvine, California-based biotechnology company with 1-10 employees focused on hair science R&D. Its leadership team combines clinical, research, and international business development expertise, suggesting clinical or licensing-oriented commercialization in the trichology vertical.

Ownership category

akta.pro rank

Product category

Biotechnology / Hair Science

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)

Keywords

• Hair science biotechnology
• Hair loss treatments
• Dermatology research
• Biotech licensing
• Cosmetic formulations

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Core offering

Applied Biology is a biotechnology company focused on hair science, developing proprietary hair and scalp formulations including Photocil, Hair Enzyme Booster, CB-101, and NoStingz. The company commercializes these innovations primarily through licensing arrangements with consumer-facing brand partners, with established licensing agreements covering Japan and India.

Differentiator

Problem solved

Functional benefit

Products and services

• Photocil

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Follica Inc. Follica is a clinical-stage biotech developing a regenerative hair growth platform combining device-based follicle disruption with topical compounds. It is directly comparable to Applied Biology as a small, private hair-biology-focused biotech developing novel therapeutics for hair-related indications.
• Concert Pharmaceuticals: Concert developed CTP-543 (deuterium-modified ruxolitinib) for alopecia areata, a focused hair-loss development program. Comparable to Applied Biology as a small-cap biotech targeting hair-loss indications with novel chemistry, though at a much more advanced clinical stage.
• Aclaris Therapeutics: Aclaris is a clinical-stage dermatology and hair-science biotech developing treatments for alopecia areata and other hair/skin conditions. It is a directly comparable specialty biotech competitor in the same therapeutic area, though at a more advanced clinical stage than Applied Biology.
• Cassiopea (Cosmo Pharmaceuticals): Cassiopea developed clascoterone (Winlevi) and has historically been active in androgenetic alopecia (breezula/clascoterone solution). As a focused hair-and-skin biotech with marketed products, it is a directly comparable specialty player for Applied Biology's hair-science niche.
• Histogen Inc. Histogen is a regenerative medicine company developing hair growth treatments based on hypoxia-induced growth factors. Like Applied Biology, it is a small, science-driven biotech focused specifically on hair biology, providing a close comparable for niche hair-science development risk.

Broad incumbents

• Pfizer Inc. Pfizer developed and commercialized ritlecitinib (Litfulo) for alopecia areata. As a major pharmaceutical incumbent with significant hair-loss R&D and commercialization infrastructure, it represents both a competitive threat and a potential acquirer/partner for a niche hair-science company like Applied Biology.
• Johnson & Johnson: Johnson & Johnson has historical dermatology and hair-loss franchises and develops therapeutics across immunology, including alopecia areata. It is a relevant broad incumbent comparable for understanding the competitive landscape Applied Biology operates within.
• Incyte Corporation: Incyte developed ruxolitinib cream (Opzelura) for vitiligo and is active in alopecia areata. While a much larger oncology/dermatology incumbent, it competes in adjacent hair/skin biology areas and represents the type of well-capitalized player that could partner with or acquire a niche player like Applied Biology.
• Almirall S.A. Almirall is a European dermatology-focused pharmaceutical company with a portfolio spanning hair loss, psoriasis, and other skin conditions. It is broadly comparable as a dermatology incumbent that partners with and acquires smaller hair/skin biotechs.

Emerging players

• Stemson Therapeutics: Stemson is a preclinical biotech using iPSC-derived cells to regenerate hair follicles. It is comparable to Applied Biology as a small private company applying advanced biotechnology to hair-growth indications, with overlapping therapeutic ambitions though differentiated technology.

Market position

Customer concentration

• LinkedInlinkedin.com/company/applied-biology-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Applied Biology